Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review)
International Journal of Oncology · 25.02.2025 · 66 (4) · 1-16
DOI: 10.3892/ijo.2025.5734 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 25.02.2025. Verfasst von Rui Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Med…. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Drug Resistance, Neoplasm, Neutrophils. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cancer is the second leading cause of death among humans worldwide. Despite remarkable improvements in cancer therapies, drug resistance remains a significant challenge. The tumor microenvironment (TME) is intimately associated with therapeutic resistance. Tumor‑associated neutrophils (TANs) are a crucial component of the TME, which, along with other immune cells, play a role in tumorigenesis, development and metastasis. In the current review, the roles of TANs in the TME, as well as the mechanisms of neutrophil‑mediated resistance to cancer therapy, including immunotherapy, chemotherapy, radiotherapy and targeted therapy, were summarized. Furthermore, strategies for neutrophil therapy were discussed and TANs were explored as potential targets for cancer treatment. In conclusion, the need to explore the precise roles, recruitment pathways and mechanisms of action of TANs was highlighted for the purpose of developing therapies that precisely target TANs and reverse drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Nanjing 214023, P.R. China.
Zitieren
APA
Hou, R., Wu, X., Wang, C., Fan, H., Zhang, Y., Wu, H., Wang, H., Ding, J., Jiang, H., & Xu, J. (2025). Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review). International Journal of Oncology, 66(4), 1-16. https://doi.org/10.3892/ijo.2025.5734
Vancouver
Hou R, Wu X, Wang C, Fan H, Zhang Y, Wu H, et al. Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review). International Journal of Oncology. 2025;66(4):1-16. doi:10.3892/ijo.2025.5734
BibTeX
@article{Hou2025,
author = {Hou, Rui and Wu, Xi and Wang, Cenzhu and Fan, Hanfang and Zhang, Yuhan and Wu, Hanchi and Wang, Huiyu and Ding, Junli and Jiang, Huning and Xu, Junying},
title = {Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review)},
journal = {International Journal of Oncology},
year = {2025},
volume = {66},
number = {4},
pages = {1--16},
doi = {10.3892/ijo.2025.5734}
}
EUVIMED